4731 - 4740 of 9145 Results
Title
Year
-
OPENTitle: Insights from a cross-sectional population-based study of 10,929 Australians living with Parkinson's disease: risk factors, comorbidities, and sex differencesJournal Name: The Lancet Regional Health - Western PacificPublisher: Elsevier BVVol: 68Issue #:Start Page: 101816End Page: 101816Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.lanwpc.2026.101816Best OA location URL: https://doi.org/10.1016/j.lanwpc.2026.101816Citation Count: 1
-
OPENTitle: Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 108Issue #:Start Page: 288End Page: 297Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.09.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6386531Citation Count: 93
- Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: Towards a harmonized segmentation protocol2015RESTRICTEDTitle: Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: Towards a harmonized segmentation protocolJournal Name: NeuroImagePublisher: Elsevier BVVol: 111Issue #:Start Page: 526End Page: 541Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2015.01.004Citation Count: 373
- Microstructural patterns in substantia nigra subregions are associated with depression and olfactory impairments in Parkinson’s disease2025RESTRICTEDTitle: Microstructural patterns in substantia nigra subregions are associated with depression and olfactory impairments in Parkinson’s diseaseJournal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 251Issue #:Start Page: 108817End Page: 108817Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2025.108817Citation Count: 3
- Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein gene2016RESTRICTEDTitle: Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein geneJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 35Issue #:Start Page: 82End Page: 87Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.12.002Citation Count: 31
-
OPENTitle: Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands for α-Synuclein FibrilsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 58Issue #: 15Start Page: 6002End Page: 6017Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b00571Best OA location URL: https://doi.org/10.7270/q24q7wrcCitation Count: 111
- Effect of selective LRRK2 kinase inhibition on nonhuman primate lung2015RESTRICTEDTitle: Effect of selective LRRK2 kinase inhibition on nonhuman primate lungJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 7Issue #: 273Start Page: 273ra15End Page: 273ra15Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aaa3634Citation Count: 371
-
OPENTitle: Minimal Clinically Important Difference for UPDRS‐III in Daily PracticeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 4Start Page: 448End Page: 450Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12632Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12632Citation Count: 65
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial2010RESTRICTEDTitle: Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 9Issue #: 12Start Page: 1164End Page: 1172Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(10)70254-4Citation Count: 681
- Serum L-ornithine-derived polyamines as indicators of Parkinson disease progression2025RESTRICTEDTitle: Serum L-ornithine-derived polyamines as indicators of Parkinson disease progressionJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 133Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-025-03007-wCitation Count: 1